These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
112 related items for PubMed ID: 6390126
1. [Treatment of type 1 diabetes with semisynthetic human insulin. 1 year's experience]. Lunetta M, Rapisarda S, Leonardi R, Leotta S, Mughini L. Minerva Endocrinol; 1984; 9(2):125-35. PubMed ID: 6390126 [No Abstract] [Full Text] [Related]
2. [Semisynthetic human insulin in the treatment of diabetes type I. Preliminary experience]. Vitacolonna E, Consoli A, Capani F. Boll Soc Ital Biol Sper; 1984 Oct 30; 60(10):1849-52. PubMed ID: 6394033 [Abstract] [Full Text] [Related]
3. [Insulin antibodies and immune complexes in long-term diabetics switched to monocomponent human insulin]. Iavicoli M, Di Mario U, Coronel GA, Musacchio N, Arduini P. Minerva Endocrinol; 1984 Oct 30; 9(2):115-20. PubMed ID: 6390124 [No Abstract] [Full Text] [Related]
4. [Semisynthetic human insulin therapy of type 1 diabetics treated with a microinfusor. Preliminary notes on insulin requirements and antibody titer]. Capani F, Consoli A, Vitacolonna E, Sensi S. Minerva Endocrinol; 1984 Oct 30; 9(2):167-71. PubMed ID: 6503905 [No Abstract] [Full Text] [Related]
5. Immunogenicity of semisynthetic human insulin. Rogala H, Lawecki J, Czyzyk A. Acta Med Pol; 1986 Oct 30; 27(1-2):45-50. PubMed ID: 3551505 [No Abstract] [Full Text] [Related]
6. [Insulin antibodies and the actual insulin requirements in children and adolescents with primary diabetes]. Karczewska K, Feluś E, Panek G, Otto-Buczkowska E, Dudziak Z. Med Dosw Mikrobiol; 1974 Oct 30; 26(4):325-30. PubMed ID: 4475336 [No Abstract] [Full Text] [Related]
7. [Treatment of type I diabetes mellitus with biosynthetic human insulin]. Guagnano MT, Anichini M, Della Loggia F, Renzetti A, Vitacolonna E, Sensi S. Boll Soc Ital Biol Sper; 1985 Sep 30; 61(9):1267-72. PubMed ID: 3907668 [No Abstract] [Full Text] [Related]
8. [Evaluation of the effects of the transition from animal insulin to biosynthetic human insulin]. Gatti A, Dell'Aversano R, Monda M, Bonavita M, Bocchino C, Giacometti F, Carleo R. Boll Soc Ital Biol Sper; 1987 Jul 31; 63(7):597-604, 610-1. PubMed ID: 3311081 [No Abstract] [Full Text] [Related]
9. [Medium-term results of treatment with biosynthetic human insulin in diabetic children already in therapy with insulin of animal origin]. Vanelli M, Bolondi O, Boselli E, Chiari G, Vittorangeli R, Rasori E, Nori G, Bernasconi S. Minerva Pediatr; 1987 Aug 31; 39(15-16):669-74. PubMed ID: 3312993 [No Abstract] [Full Text] [Related]
10. [Insulin treatment of type I diabetes--a review]. Arnqvist H. Lakartidningen; 1986 Jun 18; 83(25):2311-4. PubMed ID: 3526055 [No Abstract] [Full Text] [Related]
11. [Antibodies against therapeutic animal insulins and homologous proteins in the course of diabetes in children and adolescents]. Karczewska K. Med Dosw Mikrobiol; 1974 Jun 18; 26(4):317-24. PubMed ID: 4475335 [No Abstract] [Full Text] [Related]
12. Efficacy and immunogenicity of human and monocomponent porcine insulin: a randomized double-blind study in diabetic patients previously treated with insulin. Storms GE, Lutterman JA, van 't Laar A. Neth J Med; 1986 Jun 18; 29(10):296-302. PubMed ID: 3540688 [No Abstract] [Full Text] [Related]